Pyxis Oncology Inc. (PYXS)

AI Score

Unlock

0.96

0.03 (2.79%)

At close: Apr 17, 2025, 3:59 PM

0.96

-0.72%

After-hours: Apr 17, 2025, 07:58 PM EDT

Pyxis Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	19.47M	12.06M	25.07M	29.44M	11.14M	14.71M	25.9M	53.06M	179.29M	198.54M	223.35M	247.09M	274.74M	133.48M	142.47M	-8.08M	8.08M	-19.69M
Short-Term Investments	107.46M	132.76M	130.65M	129.06M	109.63M	118.25M	116.77M	96.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.16M	n/a	39.38M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	449K	109K	3.61M	2.25M	-8.08M	109K	-19.69M
Receivables	n/a	n/a	n/a	8M	21K	n/a	n/a	n/a	598K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	1.00	n/a	n/a	n/a	n/a	6.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.75M	4.05M	5.31M	1.47M	4.27M	6.13M	6.64M	1.47M	5.41M	1.47M	1.47M	1.47M	2.17M	859K	n/a	n/a	15K	n/a
Total Current Assets	132.44M	148.87M	161.04M	172.38M	124.6M	139.09M	149.3M	156.18M	186.61M	202.81M	226.59M	251.26M	278.67M	134.34M	142.94M	8.08M	8.1M	19.69M
Property-Plant & Equipment	22.14M	22.82M	23.68M	24.11M	24.81M	25.3M	25.93M	26.62M	24.77M	21.09M	15.97M	995K	1.24M	1.54M	1.85M	n/a	1.94M	n/a
Goodwill & Intangibles	2.6M	23.62M	23.68M	23.73M	24.31M	22.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	24.74M	46.44M	47.35M	47.84M	49.12M	47.6M	25.93M	26.62M	24.77M	21.09M	15.97M	1.44M	1.35M	5.15M	4.11M	-8.08M	2.05M	-19.69M
Total Assets	157.18M	195.31M	208.39M	220.22M	173.73M	186.69M	175.23M	182.8M	211.38M	223.9M	242.56M	252.7M	280.02M	139.49M	147.05M	n/a	10.15M	n/a
Account Payables	4.86M	4.87M	5.47M	2.29M	3.9M	3.31M	1.3M	4.03M	7.1M	5.51M	7.82M	2.06M	11.95M	1.93M	1.27M	n/a	1.08M	n/a
Deferred Revenue	n/a	n/a	-11.43M	n/a	7.66M	7.19M	n/a	n/a	n/a	n/a	n/a	n/a	6.33M	5.46M	2.24M	n/a	1.95M	n/a
Short-Term Debt	n/a	n/a	1.34M	n/a	1.23M	1.2M	527K	n/a	n/a	n/a	n/a	n/a	n/a	325K	n/a	n/a	n/a	n/a
Other Current Liabilities	4.63M	n/a	-1.34M	n/a	6.52M	-2.41M	-527K	n/a	1.09M	n/a	n/a	n/a	3.63M	9.3M	4.43M	n/a	116K	n/a
Total Current Liabilities	17.68M	20.32M	16.9M	14.14M	25.76M	28.33M	9.22M	11.6M	31.63M	19.09M	14.92M	19.19M	18.71M	16.84M	8.41M	n/a	3.69M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	194.09M	196.22M	n/a	21.94M	n/a
Total Long-Term Liabilities	18.75M	21.31M	21.7M	21.92M	22.26M	20.41M	20.73M	19.04M	18.92M	16.05M	15.68M	2.06M	12.12M	194.09M	196.22M	n/a	22.11M	n/a
Total Liabilities	36.43M	41.63M	38.59M	36.06M	48.02M	48.75M	29.95M	30.64M	50.55M	35.15M	30.6M	19.19M	18.71M	210.93M	204.64M	n/a	25.8M	n/a
Total Debt	20.2M	20.54M	20.87M	20.78M	21.33M	21.62M	21.26M	20.25M	18.92M	16.05M	15.68M	n/a	165K	325K	481K	n/a	780K	n/a
Common Stock	60K	59K	59K	59K	45K	44K	39K	37K	34K	32K	32K	32K	32K	2K	2K	n/a	1K	n/a
Retained Earnings	-363.56M	-327.99M	-306.78M	-289.48M	-286.23M	-270.63M	-247.58M	-231.68M	-212.44M	-176.33M	-148.66M	-123.1M	-91.72M	-74.89M	-60.71M	n/a	-15.74M	n/a
Comprehensive Income	170K	351K	-102K	-60K	63K	-105K	-85K	696K	n/a	0.00	n/a	0.00	-0.00	-21.94M	n/a	-15.64M	0.00	-2.87M
Shareholders Equity	120.75M	153.68M	169.79M	184.16M	125.7M	137.95M	145.28M	152.16M	160.82M	188.75M	211.97M	233.51M	261.31M	-71.44M	-57.59M	6.3M	-15.64M	19.07M
Total Investments	107.46M	132.76M	130.65M	129.06M	109.63M	118.25M	116.77M	96.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.16M	n/a	39.38M